Morimatsu Industry Co., Ltd., the privately owned Japanese
pioneer of tank technology, has acquired Pharmadule AB of Sweden,
the world leader of modular manufacturing facilities for the
pharmaceutical & biopharmaceutical industries. The companies
have been working together since the fall of 2009 and signed a
collaboration agreement in January, 2010. The two companies'
offerings complement each other perfectly and together the two
organisations will form a strong combination. The new company will
be named Pharmadule Morimatsu AB, and is headquartered in
Stockholm, Sweden.
The acquisition is a natural step of a cooperation that started
2 years ago. Through the acquisition Morimatsu gains access to the
modular construction technology that Pharmadule has developed and
which can be adapted for various industries. Through Morimatsu's
presence in China and its extensive experience in process systems,
Pharmadule can take advantage of more cost effective manufacturing
and supplement Morimatsu's product portfolio of process skids and
modules.
Shanghai Morimatsu Pharmaceutical Equipment Engineering
Co., Ltd. (SMP), a member of the Morimatsu group, has specialized
in the fabrication of process skids and modules for the
pharmaceutical and biopharmaceutical industries as well as for the
cosmetics and food and beverage industries. SMP is working closely
together with Pharmadule Morimatsu to create additional value for
the customers. "We can now offer not only modular manufacturing
buildings but also the process unit operations in the form of
process skids and process modules. This is the first time a
supplier can offer a truly integrated production service to its
clients, all fabricated in the same workshop", says Daniel Ding,
CEO of Pharmadule Morimatsu.
The business of designing and delivering modular manufacturing
facilities will be conducted by Pharmadule Morimatsu which will
focus on engineering, project management and validation. The
company also has operations in the US, China and Japan as well as
representation in various markets globally.
Pharmadule Morimatsu AB will continue and develop the business
that Pharmadule has carried out over the last 25 years.
For more information please contact:
Ulf Danielsson, Chief Operating Officer, Pharmadule Morimatsu
AB
Phone: +46 8 587 42 000, Mobile: +46 70 672
8520
E-mail: ulf.danielsson@pharmadule.com